Analytical Data
-
基因名
SLC22A18AS
- Application
-
别名
SLC22A18AS; BWR1B; BWSCR1B; ORCTL2S; SLC22A1LSBeckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein; Organic cation transporter-like protein 2 antisense protein; Solute carrier family 22 member 1-like antisense protein; Solute carrier family 22 member 18 antisense protein; p27-Beckwith-Wiedemann region 1 B; p27-BWR1B
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N1D0
-
表达区间
1-253 aa
-
氨基酸序列
MGELPGSEGM WENCPLGWVK KKASGTLAPL DFLLQRKRLW LWASEPVRPQ PQGIHRFREA RRQFCRMRGS RLTGGRKGFG SSGLRFGRGG FSEEVMPQPV LKAMRCAEGA WWFSPDGPAG SSIWPAEG AEGLPGQLGR DRLEVVYSVP DNVPGQNGSR RPLVCKITGK CLSVCSEENA KAGGCSAFPL LLSQLGARMT GREHAHKGPE LTTPDSGLPR PPNPALAGFR ALAQHSPPLG TSTPSAVLLS T
-
分子量
27.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC22A18AS is a long non-coding RNA that has gained attention in recent years due to its emerging role in various biological processes and diseases. Located in the vicinity of the SLC22A18 gene, which encodes a solute carrier responsible for transporting essential molecules, SLC22A18AS has been implicated in the regulation of gene expression and involvement in epigenetic modifications. Research indicates that this non-coding RNA may play a crucial role in metabolic pathways, particularly in the context of obesity and diabetes, as well as in cancer progression and tumorigenesis. As a regulatory element, SLC22A18AS is thought to influence the interplay between transcriptional and post-transcriptional mechanisms, thus impacting cellular functions. The recombinant protein studies of SLC22A18AS could provide valuable insights into its structural characteristics and functional roles, potentially revealing new therapeutic targets for metabolic disorders and malignancies. Understanding the biogenesis and molecular interactions of SLC22A18AS may open avenues for innovative diagnostic and treatment strategies, highlighting its significance in the realm of non-coding RNA research and personalized medicine. As such, investigating SLC22A18AS recombinant proteins represents a promising frontier in the exploration of molecular biology and its applications in clinical settings.
